Skip to content

Arrow IPN037693

by Teleflex Incorporated

Arrow IPN037693 (ASK-45854-PECL1) is a Class II device made by Teleflex Incorporated, cleared under FDA 510(k) K071538 on 30 Aug 2007 and listed in FDA GUDID since 30 Nov 2017 (UDI-DI 10801902130423), active as of 23 Oct 2026. 53 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

6 ongoing

This device is named in the recall

Documents

510(k) K071538

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number10801902130423 UDI-DI Date30 Nov 2017ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK071538 Date30 Aug 2007DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K071538 decided 30 Aug 2007 Active
  • FDA GUDID UDI-DI 10801902130423 listed 30 Nov 2017 Listed

Recalls

54 recalls · 6 ongoing · FDA

    • Ongoing Z-2376-2026 FDA Class I initiated 21 Apr 2026 on shared 510(k) K071538

    Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.

    • Ongoing Z-1914-2026 FDA Class II initiated 11 Mar 2026

    Due to receiving a notice from a supplier that the liquid adhesive was incorrectly manufactured

    • Ongoing Z-2123-2026 FDA Class II initiated 7 Jan 2026

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • 2 recalls, same reason

    • Ongoing Z-0003-2024 FDA Class I initiated 10 Aug 2023
    • Ongoing Z-0002-2024 FDA Class I initiated 10 Aug 2023

    This recall has been initiated due to reports that the product code and product name were incorrectly listed on the lidstock of affected kits.

    • Ongoing Z-1604-2022 FDA Class II initiated 25 May 2022

    Facility Temperature excursions (from June 2021-August 2021) prior to delivery; exposure to higher temperatures may have impacted product effectiveness. All lots received between 06/01/21-9/30/21.

  • 2 recalls, same reason

    • Terminated Z-0352-2023 FDA Class I initiated 27 Oct 2022
    • Terminated Z-0351-2023 FDA Class I initiated 27 Oct 2022

    There is the potential for inadequate connection between the top and bottom housings of the Micro Clave Clear Connectors included in the Arrow MAC Two-Lumen Central Venous Access Kit and the Arrow Pressure Injectable Arrowg+ard Blue Plus Three-Lumen CVC Kit.

  • 17 recalls, same reason

    • Terminated Z-2000-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1994-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1997-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1995-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1987-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1991-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1993-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1992-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1996-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1990-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1980-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1981-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1988-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1998-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1989-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1999-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1979-2018 FDA Class II initiated 11 Apr 2018

    Product sterility may be compromised due to unsealed packaging.

    • Terminated Z-1326-2018 FDA Class II initiated 22 Dec 2017

    Certain lots of cardiovascular catheters may not be completely sealed and so sterility of the product cannot be guaranteed.

  • 8 recalls, same reason

    • Terminated Z-0995-2018 FDA Class II initiated 27 Nov 2017
    • Terminated Z-0998-2018 FDA Class II initiated 27 Nov 2017
    • Terminated Z-1005-2018 FDA Class II initiated 27 Nov 2017
    • Terminated Z-0997-2018 FDA Class II initiated 27 Nov 2017
    • Terminated Z-0994-2018 FDA Class II initiated 27 Nov 2017
    • Terminated Z-1004-2018 FDA Class II initiated 27 Nov 2017
    • Terminated Z-1003-2018 FDA Class II initiated 27 Nov 2017
    • Terminated Z-0999-2018 FDA Class II initiated 27 Nov 2017

    Some of the products listed in the recall may be missing a sticker that contains the lot number, expiration date, and Unique Device Identification (UDI) information.

  • 7 recalls, same reason

    • Terminated Z-1163-2018 FDA Class II initiated 14 Nov 2017
    • Terminated Z-1162-2018 FDA Class II initiated 14 Nov 2017
    • Terminated Z-1164-2018 FDA Class II initiated 14 Nov 2017
    • Terminated Z-1166-2018 FDA Class II initiated 14 Nov 2017
    • Terminated Z-1159-2018 FDA Class II initiated 14 Nov 2017
    • Terminated Z-1161-2018 FDA Class II initiated 14 Nov 2017
    • Terminated Z-1165-2018 FDA Class II initiated 14 Nov 2017

    Products do not contain the Central Venous Catheter Placement Procedures Note or the Central Line Insertion Checklist, which is a tool intended to guide clinicians in the use of best practices during central line insertions.

  • 5 recalls, same reason

    • Terminated Z-0651-2018 FDA Class II initiated 17 Oct 2017
    • Terminated Z-0655-2018 FDA Class II initiated 17 Oct 2017
    • Terminated Z-0649-2018 FDA Class II initiated 17 Oct 2017
    • Terminated Z-0653-2018 FDA Class II initiated 17 Oct 2017
    • Terminated Z-0647-2018 FDA Class II initiated 17 Oct 2017

    These finished good kits may contain the incorrect Springwire Guide (SWG).

    • Terminated Z-2330-2017 FDA Class II initiated 9 May 2017

    Arrow International is recalling the affected product because the packaging may not be completely sealed, which may compromise sterility.

    • Terminated Z-1879-2017 FDA Class II initiated 17 Mar 2017

    Arrow International is recalling due to possible voids in the catheter hub, which could lead to an interlumen crossover.

    • Terminated Z-2136-2016 FDA Class II initiated 2 Jun 2016

    Arrow is recalling these products due to the possibility that although the kit is labeled as containing a 20 cm catheter, a 16 cm catheter may be packaged in the kit.

    • Terminated Z-1082-2015 FDA Class II initiated 2 Jan 2015

    Foreign material found within the kits. The foreign material, white or black particles and/or thread, is visible and can beidentified by the user.

    • Terminated Z-1005-2015 FDA Class II initiated 16 Dec 2014

    the Instructions for Use (IFU) were inadvertently removed from the kit.

    • Terminated Z-1633-2014 FDA Class II initiated 17 Jul 2013

    The labeling states that the kit contains Introducer Needle: Echogenic 18 Ga. x 2.5 (6.35cm) XTW and 5mL ArroW Raulerson Spring-Wire Introduction Syringe; however, the kit contains, and should state, Introducer Needle: 18 Ga. x 2.5 (6.35cm) XTW and 5mL ArroW Raulerson Spring-Wire Introduction Syringe. As a result of this labeling inconsistency, if the clinician were to place the needle under x-r

    • Terminated Z-1823-2012 FDA Class II initiated 7 Jun 2012

    Arrow is recalling the product due to the possibility of voids in the catheter hub which could lead to an interlumen crossover.

    • Terminated Z-2491-2010 FDA Unclassified (pre-2012) initiated 29 Jul 2010

    Incorrectly assembled 18 Ga x 2 1/2 Introducer Needle

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Timeline

56 dated events

  1. Recall initiated FDA recalls Z-1999-2018
  2. Recall initiated FDA recalls Z-1979-2018
  3. Recall initiated FDA recalls Z-1604-2022
  4. Recall initiated FDA recalls Z-0352-2023
  5. Recall initiated FDA recalls Z-0351-2023
  6. Recall initiated FDA recalls Z-0003-2024
  7. Recall initiated FDA recalls Z-0002-2024
  8. Recall initiated FDA recalls Z-2123-2026
  9. Recall initiated FDA recalls Z-1914-2026
  10. Recall initiated FDA recalls Z-2376-2026

46 earlier events are in the sections above.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Arrow
Generic name
Epidural anaesthesia set, non-medicated
Model / Ref / Catalog
IPN037693, ASK-45854-PECL1
Primary DI / UDI-DI
10801902130423
510(k) Number
FDA product code
FOZ
GMDN term
Epidural anaesthesia set, non-medicated
Device class
Class II
Regulation number
880.5200
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code FOZ (Catheter,intravascular,therapeutic,short-term less than 30 days).

Other devices from Teleflex Incorporated

  • Arrow IPNB00820 Open recall

    Class II
  • Arrow IPNB00826 Open recall

    Class II
  • Arrow IPNB00822 Open recall

    Class II
  • Arrow IPNB00827 Open recall

    Class II

See all devices from Teleflex Incorporated →

Properties

  • Supplied sterile
  • Single use
  • Prescription use
  • Convenience kit
  • Combination product
  • Lot / batch number
  • Expiration date
  • Manufacturing date
Other properties (7, all answered No)